Page 686 - Small Animal Clinical Nutrition 5th Edition
P. 686

710        Small Animal Clinical Nutrition



                    Box 34-3. NSAIDs and NSAID Dosage When Feeding a Veterinary Therapeutic Food
        VetBooks.ir  Designed for Patients with Osteoarthritis.



                                                                                    a
                    Nonsteroidal antiinflammatory drugs (NSAIDs) are the most common  nary therapeutic food on the dose of an NSAID (carprofen) required
                                                                                                        b
                    class of analgesics used to control pain in canine patients with  to manage clinical signs in dogs with osteoarthritis, significant effects
                    osteoarthritis. In dogs, the efficacy of NSAIDs for relief of clinical signs  were noted in the dogs consuming the therapeutic food. Pet owners
                    of osteoarthritis is well documented. However, in some patients, glu-  observed significantly greater pain reduction in dogs consuming the
                    cocorticoids, narcotic and non-narcotic medications may be indicated  veterinary therapeutic food compared to the control food. Carprofen
                    for control of pain and clinical signs. Pain control in cats is more chal-  dose reductions were possible in 43% of dogs consuming the thera-
                    lenging because of their limited ability to metabolize drugs requiring  peutic food vs. 32% of dogs eating the control food. Carprofen dose
                    glucuronide conjugation. Currently in the United States, there are no  increases were necessary in 11% of the dogs consuming the control
                    NSAIDs labeled for long-term use in cats. However, with careful dos-  food and in only 2% of dogs consuming the therapeutic food. For the
                    ing regimens both aspirin and meloxicam have been used for man-  group receiving the therapeutic food, the mean carprofen dose reduc-
                    agement of chronic pain and osteoarthritis in cats. Although they are  tion was 25%. Significantly greater reductions in carprofen dose
                    an effective part of multifaceted therapy, NSAIDs have not been shown  (mg/lb body weight) were possible in the dogs consuming the thera-
                    to alter the progression of osteoarthritis.As a class,NSAIDs may cause  peutic food compared with the control group.This study indicates that
                    side effects related to gastrointestinal, hepatic, renal and hematopoi-  nutritional management using a food with high levels of total omega-
                    etic systems. Because of their unique metabolism, cats are more sen-  3 fatty acids and eicosapentaenoic acid may allow for reduction in the
                    sitive to these side effects than dogs. When NSAIDs are prescribed,  dose of NSAIDs necessary to control clinical signs in dogs with
                    owners should be made aware of clinical signs indicative of adverse  osteoarthritis.
                    side effects of these products. Careful titration of the dosage of
                    NSAIDs is recommended for each individual patient. The addition of  ENDNOTES
                    other therapeutic modalities may affect the appropriate NSAID dose.  a. Prescription Diet j/d Canine. Hill’s Pet Nutrition, Inc., Topeka, KS,
                    Dogs in the initial phases of physical rehabilitation will benefit from  USA.
                    effective analgesia. Conversely, the initiation of appropriate therapeu-  b. Allen TA. A multi-center practice-based study of a therapeutic food
                    tic nutrition may allow for a reduction in the daily NSAID dose.  and a non-steroidal anti-inflammatory drug in dogs with
                      In a 90-day prospective, randomized (dietary treatments), double-  osteoarthritis. Hill’s Pet Nutrition, Inc., Topeka, KS, USA. 2004.
                    masked, controlled study designed to evaluate the effect of a veteri-  The Bibliography for Box 34-3 can be found at www.markmorris.org.


                  loss can be alternated at monthly intervals until ideal body  erinary therapeutic foods marketed in North America for cats
                  weight is achieved.This approach will maximize the benefits of  with osteoarthritis. If the food in question cannot be found in
                  the weight-reduction food and the therapeutic food for  this table, the manufacturer should be contacted. Man-
                  osteoarthritis. Combining the foods (i.e., providing half the  ufacturers’ addresses, websites and toll-free customer service
                  calories from each food each day) is not recommended and  numbers are listed on pet food labels. If the manufacturer can-
                  would be expected to compromise the benefits of both foods.  not provide the necessary information, food selection should be
                  Figure 34-7 provides an overview of these feeding options.  limited to foods for which this information is available.
                                                                      Comparing a food’s key nutritional factor content with the rec-
                  Assess and Select the Food                          ommended levels is fundamental to food selection.
                  After the patient has been assessed and, if necessary, body con-  Another criterion for selecting a food that may become
                  dition returned to normal, an appropriate veterinary therapeu-  increasingly important in the future is evidence-based clinical
                  tic food should be selected to aid in the long-term management  nutrition. Practitioners should know how to determine risks
                  of osteoarthritis.The steps to assessing foods include: 1) ensur-  and benefits of nutritional regimens and counsel pet owners
                  ing the nutritional adequacy of the food has been determined  accordingly. Currently, veterinary medical education and con-
                  by a credible regulatory agency such as AAFCO (See product  tinuing education are not always based on rigorous assessment
                  label.) and 2) comparing the food’s key nutritional factors with  of evidence for or against particular management options. Still,
                  the recommended levels. Because foods for the management of  studies have been published to establish the nutritional benefits
                  osteoarthritis are used in place of regular maintenance foods,  of certain pet foods. Chapter 2 describes evidence-based clini-
                  the key nutritional factors include those for promoting long-  cal nutrition in detail and applies its concepts to various veteri-
                  term general health by managing nutrition-related risk factors  nary therapeutic foods.
                  for kidney and heart disease.                         Treats should not be fed in excessive amounts, if at all. It is
                    Table 34-5 provides key nutritional factor profiles for select-  best to limit treats to less than 10% of the total food fed on a
                  ed commercial canine veterinary therapeutic foods marketed to  volume, weight or calorie basis. Consider having owners
                  provide an arthritis benefit and compares them to the key  switch to smaller treats or break larger treats in half and feed
                  nutritional factors for osteoarthritis. Currently there are no vet-  pieces instead of full treats. Too many treats will dilute the
   681   682   683   684   685   686   687   688   689   690   691